Do you help find a donor, or only treat once one is identified?

Bone Marrow Transplant in Istanbul

Medically reviewed by Assoc. Prof. Emre Yılmaz · hematology, bone marrow transplant
Reviewed 02 Jul 2026 · next review Jan 2027

Consent verified

Reviewed by Assoc. Prof. Emre Yılmaz
02 Jul 2026 · consent verified

In short

Allogeneic BMT at a JCI isolation unit costs $65,000–95,000 — about 71% less than Germany (donor search excluded). A free 72h second opinion tells you if transplant is indicated.

Allogeneic bone marrow transplant at a JCI-accredited Istanbul isolation unit costs $65,000–95,000 — about 71% less than typical German prices for the same protocol (donor search excluded). A free 72-hour tumor-board second opinion tells you whether transplant, and which type, is indicated in your case.

What it costs

UPDATED Q3 2026PLACEHOLDER — PENDING Q3 2026 QUOTES

Allogeneic bone marrow transplant

$65,000–95,000

Germany typical $280,000 · −71%

Autologous bone marrow transplant

$38,000–55,000

Germany typical $150,000 · −69%

Includes conditioning, the transplant itself, 21–45 days in an isolation ward depending on type, and a 90-day follow-up protocol. Donor-registry fees and long-term immunosuppression after day 90 are itemized separately. Ranges come from partner-hospital quotes, updated quarterly.

Get an exact quote for your case

What it costs

Q3 2026

Allogeneic BMT

$65,000–95,000

Autologous BMT

$38,000–55,000

Germany: $280,000 / $150,000 · placeholder

Get an exact quote for your case

When transplant is indicated

Considered for certain blood cancers, usually after chemotherapy brings the disease into remission. Allogeneic uses a donor's cells and treats diseases autologous transplant cannot — the right type depends on diagnosis and donor availability.

Transplant is considered for certain leukemias, lymphomas and other blood cancers, usually after standard chemotherapy has brought the disease into remission or control. Allogeneic transplant uses a matched donor's stem cells and carries higher risk but can treat diseases autologous (own-cell) transplant cannot; the right type depends on diagnosis, disease status and donor availability.

Transplant is typically considered when

Disease is in remission or well-controlled after induction chemotherapy · a matched donor is available (allogeneic) or enough of the patient's own cells can be harvested (autologous) · patient fit for the conditioning regimen

The board may advise against transplant, or delay it, when

Disease is not adequately controlled going in · no suitable donor identified yet for an allogeneic-only indication · comorbidities make conditioning too high-risk

Not sure which type applies to you?

Send your reports — the tumor board answers in 72 hours. Free, no travel.

Upload reports

The transplant

Allogeneic BMTAllogeneic bone marrow transplant

donor search excluded · 30–45 days inpatient

Conditioning clears diseased marrow, then a matched donor's stem cells are infused. Isolation ward stay while new marrow engrafts, monitored for graft-versus-host disease.After a conditioning regimen (chemotherapy, sometimes with radiotherapy) clears diseased marrow, a matched donor's stem cells are infused. The patient remains in an isolation ward while the new marrow engrafts and immunity rebuilds, with close monitoring for graft-versus-host disease.

Autologous BMTAutologous bone marrow transplant

own cells · 21–30 days inpatient

Patient's own stem cells harvested and stored, then re-infused after high-dose conditioning. No donor-match risk; disease must respond to this approach.The patient's own stem cells are harvested and stored beforehand, then re-infused after high-dose conditioning chemotherapy clears the diseased marrow. No donor-match risk, but the disease itself must be responsive to this approach.

Typical timeline

Arrival → conditioning

Inpatient

Fit to fly home

Allogeneic BMT

5–10 days

30–45 nights

day 60–90

Autologous BMT

5–10 days

21–30 nights

day 45–60

Not sure which type applies to you?

Free 72h answer — upload reports

Who leads the transplant

Assoc. Prof. Emre Yılmaz

Hematology · bone marrow transplant · 12 yrs · 610 cases

Profile + video →

Hospital options

Two states of the same component — before and after your personal quote.

state 1 · pre-quote (anonymized)

Hospital AJCI

$9,200–11,800

Hospital BJCI

$8,500–10,400

Hospital C

$10,900–12,600

Names revealed with your personal quote

state 2 · post-quote (named)

Pera Oncology Center

JCI ACCREDITED · 2024

Named in your quote[placeholder name]

Your itemized quote$78,500

Ask about this quote

Fair questionsFair questions about bone marrow transplant

Our role starts once a donor pathway is underway or autologous is confirmed. Donor-registry search is separate and its fees are never bundled into the quote.

Our role starts once a donor-search pathway is underway or an autologous approach is confirmed appropriate — international donor-registry search itself is a separate, specialized process we don't run, and its fees are never bundled into the hospital quote so you can see them clearly.

Every cancer case is individual. Assessments are based on the reports you provide and do not replace in-person examination. Survival statistics are population-level data, not personal predictions.

Chemotherapy pricing →PET-CT staging package →